{"id":"https://openalex.org/G1948064044","display_name":"Establishment of A New Strategy for the Treatment of Atherosclerosis by Activating Reverse Cholesterol Transport","description":"We identified GPI-anchored type HDL- and apo A-I- binding protein with molecular weight of 80 KDa from human monocyte-derived macrophages by ligand blotting analysis.Phospholipase C (PI-PLC) treatment of the cells decreased both the binding of HDL to and subsequent cholesterol efflux from the cells. From the cultured human macrophages, the 80 KDa HDL/apo A-I binding protein was purified with HDL-affmity column. The protein was digested with endopeptidase and the resultant fragments were sequenced for the determination of internal amino acid sequences. Two parts of 1 1 amino acid sequences completely matched those of moesin. Treatment of macrophages with anti-human moesin antibody blocked the binding of HDL and apo A-I as well as HDL- and apo A-I-mediated cholesterol efflux from human macrophages. Flowcytometric, immunohistochemical and two-dimensional immunoblotting analyzes using anti-moesin antibodies revealed that the moesin-like, GPI-anchored type HDL-binding protein is expressed on the cell surface and exclusively on monocyte-derived macrophages. Thus, we demonstrate that a moesin-like protein expressed on cell surface plays a crucial role in cholesterol efflux from macrophages as one of the specific HDL/apo A-I binding proteins.","funder_award_id":"12670666","funder":{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","doi":"https://doi.org/10.13039/501100001691"},"funded_outputs":["https://openalex.org/W2109469370"],"funded_outputs_count":1,"parent_awards":[],"sub_awards":[],"sub_awards_count":0,"amount":3900000.0,"currency":"JPY","amount_usd":null,"amount_usd_basis":null,"recipients":[],"recipient_countries":[],"recipient_regions":[],"research_scope":{"is_research":true,"basis":"funder_default","tier":1},"funding_type":"research","funder_scheme":"Grant-in-Aid for Scientific Research (C)","start_date":null,"end_date":null,"start_year":null,"end_year":null,"landing_page_url":"https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-12670666/","doi":null,"provenance":"kaken","lead_investigator":{"given_name":"Naohiko","family_name":"SAKAI","orcid":null,"role_start":null,"affiliation":{"name":"Osaka University Graduate School of medicine","country":"Japan","ids":[{"id":"https://nrid.nii.ac.jp/nrid/1000080294073","type":"nrid","asserted_by":"kaken"}]},"author":{"id":"https://openalex.org/A5017645796","display_name":"Naohiko Sakai","orcid":null},"institutions":[{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}]},"co_lead_investigator":null,"investigators":null,"works_api_url":"https://api.openalex.org/works?filter=awards.id:G1948064044","primary_topic":{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.9995,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.9995,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12955","display_name":"Atherosclerosis and Cardiovascular Diseases","score":0.0002,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.0001,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/reverse-cholesterol-transport","display_name":"reverse cholesterol transport","score":0.856},{"id":"https://openalex.org/keywords/atherosclerosis","display_name":"atherosclerosis","score":0.747},{"id":"https://openalex.org/keywords/apolipoprotein-a-i","display_name":"apolipoprotein A-I","score":0.899},{"id":"https://openalex.org/keywords/moesin","display_name":"moesin","score":0.866},{"id":"https://openalex.org/keywords/macrophages","display_name":"macrophages","score":0.806},{"id":"https://openalex.org/keywords/cholesterol-efflux","display_name":"cholesterol efflux","score":0.989},{"id":"https://openalex.org/keywords/gpi-anchored-proteins","display_name":"GPI-anchored proteins","score":0.793},{"id":"https://openalex.org/keywords/phospholipase-c","display_name":"phospholipase C","score":0.877}],"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391}],"institution_awarded":[{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"updated_date":"2026-11-13T03:01:57.000Z","created_date":"2026-07-13T04:17:19.000Z"}
